Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN)
CUSIP: 28617K101
Q3 2024 13F Holders as of 30 Sep 2024
- Type / Class
- Equity / Common Stock, $0.001 par value
- Shares outstanding
- 78,762,953
- Total 13F shares
- 18,485,827
- Share change
- +165,229
- Total reported value
- $46,028,922
- Price per share
- $2.49
- Number of holders
- 33
- Value change
- +$410,879
- Number of buys
- 11
- Number of sells
- 6
Quarterly Holders Quick Answers
What is CUSIP 28617K101?
CUSIP 28617K101 identifies ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value in SEC institutional holdings data.
Need full ownership history?
Open the full security ownership history page.
Next holder-history checks
These links keep the next click tied to holder verification, nearby quarters, or outside-13F ownership context.
- Back to full security ownership history for the broader multi-quarter picture.
- Latest 13F filings for newly reported positions across managers.
- Latest Schedule 13D/13G reports for ownership changes outside the 13F cadence.
- SEC investors directory for manager drilldown.
Explore More Reporting Periods
Jump to adjacent filing periods for faster comparison and easier crawl discovery.
Recent filing periods for CUSIP 28617K101:
Top shareholders of ELDN - Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (13F + 13D/G + 3/4/5)
Grouped by holder across the latest SEC ownership disclosures. Ownership % is shown only when it is directly reported or safely comparable across share classes.
Methodology: rows are grouped by holder and ranked by the holder's primary source value. — indicates unavailable or non-comparable values; "mixed-class rows" means the latest filing spans non-comparable classes.
| Holder | Source | Role / Reporting | Ownership % | Shares | Holdings Value | 12M Net Δ | As of | Details |
|---|---|---|---|---|---|---|---|---|
| BVF INC/IL |
13F
|
Company |
8%
|
6,293,282
|
$16,614,264 | — | 30 Jun 2024 | |
| ARMISTICE CAPITAL, LLC |
13F
|
Company |
3%
|
2,336,000
|
$6,167,040 | — | 30 Jun 2024 | |
| Zimmer Partners, LP |
13F
|
Company |
2.7%
|
2,109,704
|
$5,569,619 | — | 30 Jun 2024 | |
| Schonfeld Strategic Advisors LLC |
13F
|
Company |
1.9%
|
1,500,000
|
$3,960,000 | — | 30 Jun 2024 | |
| SPHERA FUNDS MANAGEMENT LTD. |
13F
|
Company |
1.6%
|
1,297,021
|
$3,424,135 | — | 30 Jun 2024 | |
| VANGUARD GROUP INC |
13F
|
Company |
1.4%
|
1,104,395
|
$2,915,603 | — | 30 Jun 2024 | |
| Woodline Partners LP |
13F
|
Company |
0.86%
|
675,243
|
$1,782,642 | — | 30 Jun 2024 | |
| Nantahala Capital Management, LLC |
13F
|
Company |
0.76%
|
600,000
|
$1,584,000 | — | 30 Jun 2024 | |
| Alyeska Investment Group, L.P. |
13F
|
Company |
0.63%
|
500,000
|
$1,320,000 | — | 30 Jun 2024 | |
| Ensign Peak Advisors, Inc |
13F
|
Company |
0.56%
|
443,001
|
$1,169,523 | — | 30 Jun 2024 | |
| GEODE CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.44%
|
344,489
|
$909,619 | — | 30 Jun 2024 | |
| Gary A. Lyons |
3/4/5
|
Director |
—
class O/S missing
|
150,437
|
$673,958 | — | 01 May 2023 | |
| STATE STREET CORP |
13F
|
Company |
0.21%
|
161,492
|
$426,339 | — | 30 Jun 2024 | |
| CM Management, LLC |
13F
|
Company |
0.2%
|
160,000
|
$422,400 | — | 30 Jun 2024 | |
| BlackRock Finance, Inc. |
13F
|
Company |
0.2%
|
155,080
|
$409,411 | — | 30 Jun 2024 | |
| RENAISSANCE TECHNOLOGIES LLC |
13F
|
Company |
0.17%
|
136,773
|
$361,081 | — | 30 Jun 2024 | |
| NORTHERN TRUST CORP |
13F
|
Company |
0.12%
|
91,893
|
$242,598 | — | 30 Jun 2024 | |
| JMAC ENTERPRISES LLC |
13F
|
Company |
0.07%
|
58,041
|
$153,228 | — | 30 Jun 2024 | |
| UBS Group AG |
13F
|
Company |
0.07%
|
55,001
|
$145,203 | — | 30 Jun 2024 | |
| INGALLS & SNYDER LLC |
13F
|
Company |
0.07%
|
51,849
|
$137,000 | — | 30 Jun 2024 | |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC |
13F
|
Company |
0.04%
|
33,400
|
$88,176 | — | 30 Jun 2024 | |
| MARCO INVESTMENT MANAGEMENT LLC |
13F
|
Company |
0.04%
|
30,344
|
$80,108 | — | 30 Jun 2024 | |
| DIMENSIONAL FUND ADVISORS LP |
13F
|
Company |
0.04%
|
30,233
|
$79,815 | — | 30 Jun 2024 | |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP |
13F
|
Company |
0.03%
|
21,788
|
$57,520 | — | 30 Jun 2024 | |
| Tower Research Capital LLC (TRC) |
13F
|
Company |
0.02%
|
16,958
|
$44,769 | — | 30 Jun 2024 | |
| MERCER GLOBAL ADVISORS INC /ADV |
13F
|
Company |
0.02%
|
16,726
|
$44,157 | — | 30 Jun 2024 | |
| CHARLES SCHWAB INVESTMENT MANAGEMENT INC |
13F
|
Company |
0.02%
|
14,987
|
$39,566 | — | 30 Jun 2024 | |
| Pathstone Holdings, LLC |
13F
|
Company |
0.02%
|
13,029
|
$34,397 | — | 30 Jun 2024 | |
| BANK OF AMERICA CORP /DE/ |
13F
|
Company |
0.01%
|
6,818
|
$18,000 | — | 30 Jun 2024 | |
| MORGAN STANLEY |
13F
|
Company |
0%
|
2,155
|
$5,689 | — | 30 Jun 2024 | |
| JPMORGAN CHASE & CO |
13F
|
Company |
0%
|
91
|
$240 | — | 30 Jun 2024 | |
| FMR LLC |
13F
|
Company |
0%
|
17
|
$45 | — | 30 Jun 2024 | |
| Walter C. Ogier |
3/4/5
|
Director |
—
class O/S missing
|
150,437
|
— | — | 01 May 2023 |
Institutional Holders of Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) as of Q3 2024
As of 30 Sep 2024,
Eledon Pharmaceuticals, Inc. - Common Stock, $0.001 par value (ELDN) was held by
33 institutional
shareholders
that filed Form 13F with the SEC.
Together, they reported ownership of
18,485,827 shares.
The largest 10 holders included
BVF INC/IL, ARMISTICE CAPITAL, LLC, VANGUARD GROUP INC, Schonfeld Strategic Advisors LLC, Zimmer Partners, LP, SPHERA FUNDS MANAGEMENT LTD., Woodline Partners LP, Nantahala Capital Management, LLC, Alyeska Investment Group, L.P., and Ensign Peak Advisors, Inc.
This page lists
33
institutional shareholders reporting positions in this security
for the Q3 2024 filing period.
| Investor | Option | Weight % | Change % | Value $ | * Price | Shares | Share Change | Activity | Report Period |
|---|
Compare Q3 2024 vs Q2 2024 Across Filers
Q2 2024 holders
31
Q3 2024 holders
33
Holder diff
2
| Investor | Q2 2024 Shares | Q3 2024 Shares | Share Diff | Share Chg % | Q2 2024 Value $ | Q3 2024 Value $ | Value Diff $ | Value Chg % |
|---|
Trend: ostatnie 8 kwartałów (+ wybrane okresy porównania).
Quarterly Holders Trend
Quarterly Value Trend
Quarterly Shares Trend
* Reported Price is the price of the security as of the portfolio date. This value is significant in that it is the last known price at which the security was still held.
An asterisk sign (*) next to the price indicates that the price is likely invalid.
An asterisk sign (*) next to the price indicates that the price is likely invalid.